Ariston, Irwin M.

HRN: 26-05-55  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2025
CEFAZOLIN 1GM (VIAL)
06/13/2025
06/19/2025
IV
1gm
Q8
Buerger’s Disease
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: